Cartesian Therapeutics shares owned by Tower Research Capital
Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Tower Research Capital
from 13F filings
Historical chart of Tower Research Capital investment in Cartesian Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Cartesian Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cartesian Therapeutics by Tower Research Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $48k | 1.8k | 27.01 |